{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:51:31Z","timestamp":1775843491035,"version":"3.50.1"},"reference-count":144,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Pathologic cardiac hypertrophy is a common consequence of many cardiovascular diseases, including aortic stenosis (AS). AS is known to increase the pressure load of the left ventricle, causing a compensative response of the cardiac muscle, which progressively will lead to dilation and heart failure. At a cellular level, this corresponds to a considerable increase in the size of cardiomyocytes, known as cardiomyocyte hypertrophy, while their proliferation capacity is attenuated upon the first developmental stages. Cardiomyocytes, in order to cope with the increased workload (overload), suffer alterations in their morphology, nuclear content, energy metabolism, intracellular homeostatic mechanisms, contractile activity, and cell death mechanisms. Moreover, modifications in the cardiomyocyte niche, involving inflammation, immune infiltration, fibrosis, and angiogenesis, contribute to the subsequent events of a pathologic hypertrophic response. Considering the emerging need for a better understanding of the condition and treatment improvement, as the only available treatment option of AS consists of surgical interventions at a late stage of the disease, when the cardiac muscle state is irreversible, large animal models have been developed to mimic the human condition, to the greatest extend. Smaller animal models lack physiological, cellular and molecular mechanisms that sufficiently resemblance humans and in vitro techniques yet fail to provide adequate complexity. Animals, such as the ferret (Mustello purtorius furo), lapine (rabbit, Oryctolagus cunigulus), feline (cat, Felis catus), canine (dog, Canis lupus familiaris), ovine (sheep, Ovis aries), and porcine (pig, Sus scrofa), have contributed to research by elucidating implicated cellular and molecular mechanisms of the condition. Essential discoveries of each model are reported and discussed briefly in this review. Results of large animal experimentation could further be interpreted aiming at prevention of the disease progress or, alternatively, at regression of the implicated pathologic mechanisms to a physiologic state. This review summarizes the important aspects of the pathophysiology of LV hypertrophy and the applied surgical large animal models that currently better mimic the condition.<\/jats:p>","DOI":"10.1093\/cvr\/cvae045","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T22:19:42Z","timestamp":1709245182000},"page":"461-475","source":"Crossref","is-referenced-by-count":20,"title":["Large animal models of pressure overload-induced cardiac left ventricular hypertrophy to study remodelling of the human heart with aortic stenosis"],"prefix":"10.1093","volume":"120","author":[{"given":"Evangelia","family":"Beslika","sequence":"first","affiliation":[{"name":"Cardiovascular R&D Centre\u2014UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine, University of Porto , Alameda Prof. Hern\u00e2ni Monteiro, 4200-319 Porto , Portugal"}]},{"given":"Adelino","family":"Leite-Moreira","sequence":"additional","affiliation":[{"name":"Cardiovascular R&D Centre\u2014UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine, University of Porto , Alameda Prof. Hern\u00e2ni Monteiro, 4200-319 Porto , Portugal"}]},{"given":"Leon J","family":"De Windt","sequence":"additional","affiliation":[{"name":"CARIM School for Cardiovascular Diseases, Faculty of Health, Medicine and Life Sciences, Maastricht University , Universiteitssingel 50, 6200 MD Maastricht , Netherlands"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0695-1187","authenticated-orcid":false,"given":"Paula A","family":"da Costa Martins","sequence":"additional","affiliation":[{"name":"Cardiovascular R&D Centre\u2014UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine, University of Porto , Alameda Prof. Hern\u00e2ni Monteiro, 4200-319 Porto , Portugal"},{"name":"CARIM School for Cardiovascular Diseases, Faculty of Health, Medicine and Life Sciences, Maastricht University , Universiteitssingel 50, 6200 MD Maastricht , Netherlands"}]}],"member":"286","published-online":{"date-parts":[[2024,3,1]]},"reference":[{"key":"2024043016350280000_cvae045-B1","author":"World_Health_Organization"},{"key":"2024043016350280000_cvae045-B2","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/cvr\/cvaa233","article-title":"Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling","volume":"117","author":"Vigil-Garcia","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2024043016350280000_cvae045-B3","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/01.CIR.0000051865.66123.B7","article-title":"Progression from compensated hypertrophy to failure in the pressure-overloaded human heart","volume":"107","author":"Hein","year":"2003","journal-title":"Circulation"},{"key":"2024043016350280000_cvae045-B4","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke statistics-2023 update: a report from the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"key":"2024043016350280000_cvae045-B5","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1038\/s41418-020-0554-8","article-title":"The proteasome activator REG\u03b3 accelerates cardiac hypertrophy by declining PP2Ac\u03b1\u2013SOD2 pathway","volume":"27","author":"Xie","year":"2020","journal-title":"Cell Death Differ"},{"key":"2024043016350280000_cvae045-B6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bcp.2013.08.006","article-title":"Animal models of human disease: challenges in enabling translation","volume":"87","author":"McGonigle","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"2024043016350280000_cvae045-B7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.biomaterials.2018.09.036","article-title":"Cardiovascular disease models: a game changing paradigm in drug discovery and screening","volume":"198","author":"Savoji","year":"2019","journal-title":"Biomaterials"},{"key":"2024043016350280000_cvae045-B8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/164_2015_31","article-title":"Translational in vivo models for cardiovascular diseases","volume":"232","author":"Fliegner","year":"2016","journal-title":"Handb Exp Pharmacol"},{"key":"2024043016350280000_cvae045-B9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000501906","article-title":"The transitional heart: from early embryonic and fetal development to neonatal life","volume":"47","author":"Tan","year":"2020","journal-title":"Fetal Diagn Ther"},{"key":"2024043016350280000_cvae045-B10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/01.RES.39.3.297","article-title":"Heart size","volume":"39","author":"Ford","year":"1976","journal-title":"Circ Res"},{"key":"2024043016350280000_cvae045-B11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and pathological cardiac hypertrophy","volume":"97","author":"Shimizu","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"2024043016350280000_cvae045-B12","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/01.RES.0000077012.11088.BC","article-title":"Phenotyping hypertrophy","volume":"92","author":"Dorn","year":"2003","journal-title":"Circ Res"},{"key":"2024043016350280000_cvae045-B13","doi-asserted-by":"crossref","first-page":"a037150","DOI":"10.1101\/cshperspect.a037150","article-title":"Determinants of cardiac growth and size","volume":"12","author":"Heallen","year":"2020","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2024043016350280000_cvae045-B14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.phrs.2009.11.012","article-title":"Molecular targets and regulators of cardiac hypertrophy","volume":"61","author":"Rohini","year":"2010","journal-title":"Pharmacol Res"},{"key":"2024043016350280000_cvae045-B15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1139\/cjpp-2019-0566","article-title":"Mechanisms for the transition from physiological to pathological cardiac hypertrophy","volume":"98","author":"Oldfield","year":"2020","journal-title":"Can J Physiol Pharmacol"},{"key":"2024043016350280000_cvae045-B16","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","article-title":"Burden of valvular heart diseases: a population-based study","volume":"368","author":"Nkomo","year":"2006","journal-title":"Lancet"},{"key":"2024043016350280000_cvae045-B17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1253\/jcj.65.353","article-title":"Molecular mechanism of cardiac hypertrophy and development","volume":"65","author":"Komuro","year":"2001","journal-title":"Jpn Circ J"},{"key":"2024043016350280000_cvae045-B18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"2024043016350280000_cvae045-B19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/B978-0-12-800883-6.00057-4","volume-title":"Quantitative Human Physiology","author":"Feher","year":"2012","edition":"2nd ed"},{"key":"2024043016350280000_cvae045-B20","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41586-020-2797-4","article-title":"Cells of the adult human heart","volume":"588","author":"Litvi\u0148ukov\u00e1","year":"2020","journal-title":"Nature"},{"key":"2024043016350280000_cvae045-B21","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41569-020-00464-6","article-title":"Complexity and plasticity of cardiac cellular composition","volume":"17","author":"Lim","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"2024043016350280000_cvae045-B22","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1073\/pnas.1214608110","article-title":"Cardiomyocyte proliferation contributes to heart growth in young humans","volume":"110","author":"Mollova","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024043016350280000_cvae045-B23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1164680","article-title":"Evidence for cardiomyocyte renewal in humans","volume":"324","author":"Bergmann","year":"2009","journal-title":"Science"},{"key":"2024043016350280000_cvae045-B24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/CIRCRESAHA.116.310058","article-title":"Cardiomyocyte proliferation","volume":"120","author":"Yutzey","year":"2017","journal-title":"Circ Res"},{"key":"2024043016350280000_cvae045-B25","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCRESAHA.119.315408","article-title":"Polyploidy in cardiomyocytes","volume":"126","author":"Derks","year":"2020","journal-title":"Circ Res"},{"key":"2024043016350280000_cvae045-B26","first-page":"27","article-title":"Polyploidy of myocyte nuclei in pressure overloaded human hearts: a flow cytometric study in left and right ventricular myocardium","volume":"5","author":"Vliegen","year":"1995","journal-title":"Am J Cardiovasc Pathol"},{"key":"2024043016350280000_cvae045-B27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10741-012-9350-y","article-title":"Cardiomyocyte autophagy: metabolic profit and loss","volume":"18","author":"Wang","year":"2013","journal-title":"Heart Fail Rev"},{"key":"2024043016350280000_cvae045-B28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1015380609464","article-title":"Energy metabolism in the hypertrophied heart","volume":"7","author":"Sambandam","year":"2002","journal-title":"Heart Fail Rev"},{"key":"2024043016350280000_cvae045-B29","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/cvr\/cvaa125","article-title":"Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies","volume":"117","author":"Ramachandra","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2024043016350280000_cvae045-B30","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1161\/CIRCRESAHA.119.315483","article-title":"Metabolic remodeling promotes cardiac hypertrophy by directing glucose to aspartate biosynthesis","volume":"126","author":"Ritterhoff","year":"2020","journal-title":"Circ Res"},{"key":"2024043016350280000_cvae045-B31","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.bbamcr.2016.02.011","article-title":"Hypoxia-driven glycolytic and fructolytic metabolic programs: pivotal to hypertrophic heart disease","volume":"1863","author":"Mirtschink","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"2024043016350280000_cvae045-B32","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nature14508","article-title":"HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease","volume":"522","author":"Mirtschink","year":"2015","journal-title":"Nature"},{"key":"2024043016350280000_cvae045-B33","doi-asserted-by":"crossref","first-page":"822969","DOI":"10.3389\/fcvm.2021.822969","article-title":"Mitochondria in pathological cardiac hypertrophy research and therapy","volume":"8","author":"Yang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2024043016350280000_cvae045-B34","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/cvr\/cvy217","article-title":"Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway","volume":"115","author":"Xu","year":"2019","journal-title":"Cardiovasc Res"},{"key":"2024043016350280000_cvae045-B35","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s12012-021-09653-2","article-title":"FABP5 deficiency impairs mitochondrial function and aggravates pathological cardiac remodeling and dysfunction","volume":"21","author":"Gao","year":"2021","journal-title":"Cardiovasc Toxicol"},{"key":"2024043016350280000_cvae045-B36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-3-319-55330-6_11","article-title":"Advances in experimental medicine and biology","volume":"982","author":"Facundo","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"2024043016350280000_cvae045-B37","doi-asserted-by":"crossref","first-page":"H2181","DOI":"10.1152\/ajpheart.00554.2011","article-title":"Oxidative stress and heart failure","volume":"301","author":"Tsutsui","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024043016350280000_cvae045-B38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/abbs\/gmw025","article-title":"The role of autophagy in cardiac hypertrophy","volume":"48","author":"Li","year":"2016","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"2024043016350280000_cvae045-B39","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nm1574","article-title":"The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress","volume":"13","author":"Nakai","year":"2007","journal-title":"Nat Med"},{"key":"2024043016350280000_cvae045-B40","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.bbrc.2013.10.135","article-title":"Autophagy-mediated degradation is necessary for regression of cardiac hypertrophy during ventricular unloading","volume":"441","author":"Oyabu","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"2024043016350280000_cvae045-B41","doi-asserted-by":"crossref","first-page":"e51632","DOI":"10.1371\/journal.pone.0051632","article-title":"Autophagy plays an essential role in mediating regression of hypertrophy during unloading of the heart","volume":"8","author":"Hariharan","year":"2013","journal-title":"PLoS One"},{"key":"2024043016350280000_cvae045-B42","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/cvr\/cvac035","article-title":"Regulation of calcium handling by autophagy: a novel mechanism limiting cardiac hypertrophy and dysfunction?","volume":"118","author":"Forte","year":"2022","journal-title":"Cardiovasc Res"},{"key":"2024043016350280000_cvae045-B43","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/cvr\/cvab112","article-title":"Loss of autophagy protein ATG5 impairs cardiac capacity in mice and humans through diminishing mitochondrial abundance and disrupting Ca2+ cycling","volume":"118","author":"Ljubojevi\u0107-Holzer","year":"2022","journal-title":"Cardiovasc Res"},{"key":"2024043016350280000_cvae045-B44","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/cells9102317","article-title":"The role of proteostasis derailment in cardiac diseases","volume":"9","author":"Brundel","year":"2020","journal-title":"Cells"},{"key":"2024043016350280000_cvae045-B45","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1113\/JP273607","article-title":"Proteasome dysfunction in cardiomyopathies","volume":"595","author":"Gilda","year":"2017","journal-title":"J Physiol"},{"key":"2024043016350280000_cvae045-B46","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/cvr\/cvab142","article-title":"Role of oxidative stress in calcific aortic valve disease and its therapeutic implications","volume":"118","author":"Greenberg","year":"2022","journal-title":"Cardiovasc Res"},{"key":"2024043016350280000_cvae045-B47","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1161\/hy1201.099615","article-title":"Cardiomyocyte apoptotic cell death in arterial hypertension","volume":"38","author":"Fortun\u0303o","year":"2001","journal-title":"Hypertension"},{"key":"2024043016350280000_cvae045-B48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/jmcc.1999.1064","article-title":"On the nature of cell death during remodeling of hypertrophied human myocardium","volume":"32","author":"Yamamoto","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"2024043016350280000_cvae045-B49","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cardiores.2004.02.013","article-title":"Myocyte hypertrophy and apoptosis: a balancing act","volume":"63","author":"van Empel","year":"2004","journal-title":"Cardiovasc Res"},{"key":"2024043016350280000_cvae045-B50","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/01.RES.0000053618.86362.DF","article-title":"Myocyte death, growth, and regeneration in cardiac hypertrophy and failure","volume":"92","author":"Nadal-Ginard","year":"2003","journal-title":"Circ Res"},{"key":"2024043016350280000_cvae045-B51","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00424-014-1468-4","article-title":"Mechano-signaling in heart failure","volume":"466","author":"Buyandelger","year":"2014","journal-title":"Pflugers Arch"},{"key":"2024043016350280000_cvae045-B52","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1161\/CIRCRESAHA.116.304937","article-title":"Mechanotransduction in cardiac hypertrophy and failure","volume":"116","author":"Lyon","year":"2015","journal-title":"Circ Res"},{"key":"2024043016350280000_cvae045-B53","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1152\/jappl.2000.88.3.1127","article-title":"Form follows function: how muscle shape is regulated by work","volume":"88","author":"Russell","year":"2000","journal-title":"J Appl Physiol"},{"key":"2024043016350280000_cvae045-B54","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1083\/jcb.153.4.763","article-title":"Alterations at the intercalated disk associated with the absence of muscle LIM protein","volume":"153","author":"Ehler","year":"2001","journal-title":"J Cell Biol"},{"key":"2024043016350280000_cvae045-B55","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1050-1738(02)00209-8","article-title":"Dilated cardiomyopathy: a disease of the intercalated disc?","volume":"13","author":"Perriard","year":"2003","journal-title":"Trends Cardiovasc Med"},{"key":"2024043016350280000_cvae045-B56","first-page":"395","article-title":"Sarcolemmal alterations in cardiac hypertrophy and degeneration","volume":"9","author":"Ferrans","year":"1976","journal-title":"Recent Adv Stud Cardiac Struct Metab"},{"key":"2024043016350280000_cvae045-B57","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.cardiores.2004.01.038","article-title":"Enhanced sarcolemmal Ca2+ efflux reduces sarcoplasmic reticulum Ca2+ content and systolic Ca2+ in cardiac hypertrophy","volume":"62","author":"Diaz","year":"2004","journal-title":"Cardiovasc Res"},{"key":"2024043016350280000_cvae045-B58","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1161\/CIRCULATIONAHA.114.008788","article-title":"Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling","volume":"131","author":"Frieler","year":"2015","journal-title":"Circulation"},{"key":"2024043016350280000_cvae045-B59","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.3390\/cells12131780","article-title":"The microenvironment of the pathogenesis of cardiac hypertrophy","volume":"12","author":"Bazgir","year":"2023","journal-title":"Cells"},{"key":"2024043016350280000_cvae045-B60","first-page":"47","article-title":"Neurohumoral, cardiac and inflammatory markers in the evaluation of heart failure severity and progression","volume":"18","author":"Polyakova","year":"2021","journal-title":"J Geriatr Cardiol"},{"key":"2024043016350280000_cvae045-B61","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.3390\/ijms20071698","article-title":"Cross-talk between neurohormonal pathways and the immune system in heart failure: a review of the literature","volume":"20","author":"De Angelis","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2024043016350280000_cvae045-B62","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1161\/CIRCULATIONAHA.118.034621","article-title":"Inflammation and NLRP3 inflammasome activation initiated in response to pressure overload by Ca2+\/calmodulin-dependent protein kinase II \u03b4 signaling in cardiomyocytes are essential for adverse cardiac remodeling","volume":"138","author":"Suetomi","year":"2018","journal-title":"Circulation"},{"key":"2024043016350280000_cvae045-B63","doi-asserted-by":"crossref","first-page":"e97054","DOI":"10.1172\/jci.insight.97054","article-title":"CaMKII\u03b4-mediated inflammatory gene expression and inflammasome activation in cardiomyocytes initiate inflammation and induce fibrosis","volume":"3","author":"Willeford","year":"2018","journal-title":"JCI Insight"},{"key":"2024043016350280000_cvae045-B64","first-page":"2749","article-title":"Myocardial pressure overload induces systemic inflammation through endothelial cell IL-33","volume":"112","author":"Chen","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024043016350280000_cvae045-B65","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/cvr\/cvu030","article-title":"Myocyte signalling in leucocyte recruitment to the heart","volume":"102","author":"Ghigo","year":"2014","journal-title":"Cardiovasc Res"},{"key":"2024043016350280000_cvae045-B66","doi-asserted-by":"crossref","first-page":"695047","DOI":"10.3389\/fphys.2021.695047","article-title":"Inflammatory cytokines, immune cells, and organ interactions in heart failure","volume":"12","author":"Li","year":"2021","journal-title":"Front Physiol"},{"key":"2024043016350280000_cvae045-B67","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1161\/CIRCULATIONAHA.119.041694","article-title":"Single-cell sequencing of mouse heart immune infiltrate in pressure overload-driven heart failure reveals extent of immune activation","volume":"140","author":"Martini","year":"2019","journal-title":"Circulation"},{"key":"2024043016350280000_cvae045-B68","doi-asserted-by":"crossref","first-page":"659666","DOI":"10.3389\/fcell.2021.659666","article-title":"Innate immune cells in pressure overload-induced cardiac hypertrophy and remodeling","volume":"9","author":"Liu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2024043016350280000_cvae045-B69","first-page":"42","article-title":"Neutrophil to lymphocyte ratio as a predictor of left ventricular hypertrophy in patients with newly diagnosed hypertension","volume":"5","author":"Af\u015fin","year":"2019","journal-title":"J Hypertens Manag"},{"key":"2024043016350280000_cvae045-B70","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.cardfail.2005.05.005","article-title":"Pharmacologic inhibition of mast cell degranulation prevents left ventricular remodeling induced by chronic volume overload in rats","volume":"11","author":"Brower","year":"2005","journal-title":"J Card Fail"},{"key":"2024043016350280000_cvae045-B71","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijcard.2007.10.031","article-title":"Blood dendritic cell levels and phenotypic characteristics in relation to etiology of end-stage heart failure: implications for dilated cardiomyopathy","volume":"131","author":"Athanassopoulos","year":"2009","journal-title":"Int J Cardiol"},{"key":"2024043016350280000_cvae045-B72","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1084\/jem.20140639","article-title":"Progressive replacement of embryo-derived cardiac macrophages with age","volume":"211","author":"Molawi","year":"2014","journal-title":"J Exp Med"},{"key":"2024043016350280000_cvae045-B73","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/cvr\/cvab376","article-title":"Myocardin-related transcription factor A in macrophages mediates pathological hypertrophy","volume":"118","author":"Sadoshima","year":"2022","journal-title":"Cardiovasc Res"},{"key":"2024043016350280000_cvae045-B74","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/cvr\/cvab110","article-title":"Myocardin-related transcription factor A regulates integrin beta 2 transcription to promote macrophage infiltration and cardiac hypertrophy in mice","volume":"118","author":"Liu","year":"2022","journal-title":"Cardiovasc Res"},{"key":"2024043016350280000_cvae045-B75","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.amjcard.2003.12.054","article-title":"Interleukin-6 (IL-6) expression and natural killer (NK) cell dysfunction and anergy in heart failure","volume":"93","author":"Vredevoe","year":"2004","journal-title":"Am J Cardiol"},{"key":"2024043016350280000_cvae045-B76","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/ehf2.12744","article-title":"The role of B cells in heart failure and implications for future immunomodulatory treatment strategies","volume":"7","author":"Garc\u00eda-Rivas","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2024043016350280000_cvae045-B77","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.exer.2015.07.009","article-title":"Myofibroblasts","volume":"142","author":"Hinz","year":"2016","journal-title":"Exp Eye Res"},{"key":"2024043016350280000_cvae045-B78","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"2024043016350280000_cvae045-B79","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1161\/CIRCULATIONAHA.119.043053","article-title":"Single-cell reconstruction of progression trajectory reveals intervention principles in pathological cardiac hypertrophy","volume":"141","author":"Ren","year":"2020","journal-title":"Circulation"},{"key":"2024043016350280000_cvae045-B80","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mam.2018.07.001","article-title":"Cardiac fibrosis: cell biological mechanisms, molecular pathways and therapeutic opportunities","volume":"65","author":"Frangogiannis","year":"2019","journal-title":"Mol Aspects Med"},{"key":"2024043016350280000_cvae045-B81","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/CIRCRESAHA.120.316958","article-title":"Myofibroblasts and fibrosis","volume":"127","author":"Gibb","year":"2020","journal-title":"Circ Res"},{"key":"2024043016350280000_cvae045-B82","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.3390\/cells10071716","article-title":"Cardiac fibrosis and fibroblasts","volume":"10","author":"Kurose","year":"2021","journal-title":"Cells"},{"key":"2024043016350280000_cvae045-B83","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.yjmcc.2013.10.019","article-title":"Myofibroblasts: trust your heart and let fate decide","volume":"70","author":"Davis","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"2024043016350280000_cvae045-B84","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1093\/cvr\/cvab228","article-title":"Management of cardiac fibrosis is the largest unmet medical need in heart failure","volume":"118","author":"D\u00edez","year":"2022","journal-title":"Cardiovasc Res"},{"key":"2024043016350280000_cvae045-B85","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/CIRCRESAHA.114.300507","article-title":"Angiogenesis and cardiac hypertrophy","volume":"114","author":"Oka","year":"2014","journal-title":"Circ Res"},{"key":"2024043016350280000_cvae045-B86","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/CIRCRESAHA.115.307778","article-title":"Revisiting cardiac cellular composition","volume":"118","author":"Pinto","year":"2016","journal-title":"Circ Res"},{"key":"2024043016350280000_cvae045-B87","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3389\/fphys.2018.00382","article-title":"Cardiac remodeling: endothelial cells have more to say than just NO","volume":"9","author":"Segers","year":"2018","journal-title":"Front Physiol"},{"key":"2024043016350280000_cvae045-B88","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fcvm.2019.00020","article-title":"Angiogenic endothelial cell signaling in cardiac hypertrophy and heart failure","volume":"6","author":"Gogiraju","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"2024043016350280000_cvae045-B89","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/j.ymthe.2022.03.002","article-title":"Intercellular transfer of miR-200c-3p impairs the angiogenic capacity of cardiac endothelial cells","volume":"30","author":"Ottaviani","year":"2022","journal-title":"Mol Ther"},{"key":"2024043016350280000_cvae045-B90","first-page":"32","article-title":"Valvular heart disease epidemiology","volume":"10","author":"Aluru","year":"2022","journal-title":"Med Sci (Basel)"},{"key":"2024043016350280000_cvae045-B91","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2024043016350280000_cvae045-B92","first-page":"e35","article-title":"ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"2024043016350280000_cvae045-B93","author":"European_Commission"},{"key":"2024043016350280000_cvae045-B94","first-page":"117","volume-title":"Principles of animal research for graduate and undergraduate students","author":"Hickman","year":"2017"},{"key":"2024043016350280000_cvae045-B95","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fcvm.2018.00120","article-title":"Genetic and tissue engineering approaches to modeling the mechanics of human heart failure for drug discovery","volume":"5","author":"Greenberg","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"2024043016350280000_cvae045-B96","doi-asserted-by":"crossref","first-page":"1213959","DOI":"10.3389\/fphys.2023.1213959","article-title":"Building blocks of microphysiological system to model physiology and pathophysiology of human heart","volume":"14","author":"Vuorenp\u00e4\u00e4","year":"2023","journal-title":"Front Physiol"},{"key":"2024043016350280000_cvae045-B97","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/cvr\/cvz161","article-title":"Small animal models of heart failure","volume":"115","author":"Riehle","year":"2019","journal-title":"Cardiovasc Res"},{"key":"2024043016350280000_cvae045-B98","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/039139880903200804","article-title":"Ovine models for chronic heart failure","volume":"32","author":"Geens","year":"2009","journal-title":"Int J Artif Organs"},{"key":"2024043016350280000_cvae045-B99","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/cvr\/14.3.161","article-title":"Myocardial morphometrics in pressure overload left ventricular hypertrophy and regression","volume":"14","author":"Breisch","year":"1980","journal-title":"Cardiovasc Res"},{"key":"2024043016350280000_cvae045-B100","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1515\/jbcpp-2018-0002","article-title":"Rabbits and men: relating their ages","volume":"29","author":"Dutta","year":"2018","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"2024043016350280000_cvae045-B101","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/cvr\/26.6.580","article-title":"Left ventricular hypertrophy in a canine model of reversible pressure overload","volume":"26","author":"Ishihara","year":"1992","journal-title":"Cardiovasc Res"},{"key":"2024043016350280000_cvae045-B102","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.hlc.2012.11.021","article-title":"A rabbit model to study regression of ventricular hypertrophy","volume":"22","author":"Zhao","year":"2013","journal-title":"Heart Lung Circ"},{"key":"2024043016350280000_cvae045-B103","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.yjmcc.2014.07.007","article-title":"Pressure overload induces IL-18 and IL-18R expression, but markedly suppresses IL-18BP expression in a rabbit model. IL-18 potentiates TNF-\u03b1-induced cardiomyocyte death","volume":"75","author":"Yoshida","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"2024043016350280000_cvae045-B104","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.athoracsur.2020.07.078","article-title":"Neonatal rabbit model for pressure-overloaded heart failure and preliminary exploration of mechanism","volume":"112","author":"Zhang","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"2024043016350280000_cvae045-B105","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/0014-4827(64)90313-1","article-title":"Structure and mass of mitochondria in the process of compensatory hyperfunction and hypertrophy of the heart","volume":"36","author":"Meerson","year":"1964","journal-title":"Exp Cell Res"},{"key":"2024043016350280000_cvae045-B106","doi-asserted-by":"crossref","first-page":"139","DOI":"10.14740\/cr578w","article-title":"Feline hypertrophic cardiomyopathy: a spontaneous large animal model of human HCM","volume":"8","author":"Freeman","year":"2017","journal-title":"Cardiol Res"},{"key":"2024043016350280000_cvae045-B107","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/hr.2016.66","article-title":"A minimally invasive endovascular rabbit model for experimental induction of progressive myocardial hypertrophy","volume":"39","author":"Tsigkas","year":"2016","journal-title":"Hypertens Res"},{"key":"2024043016350280000_cvae045-B108","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jfms.2006.02.008","article-title":"Effects of enalapril in cats with pressure overload-induced left ventricular hypertrophy","volume":"9","author":"Ishikawa","year":"2007","journal-title":"J Feline Med Surg"},{"issue":"4 pt. 2","key":"2024043016350280000_cvae045-B109","first-page":"H1307","article-title":"Progressive feline pressure-overload: noninvasive assessment correlates with abnormalities in single cells","volume":"264","author":"Pollack","year":"1993","journal-title":"Am J Physiol"},{"key":"2024043016350280000_cvae045-B110","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/01.RES.0000179722.79295.d4","article-title":"Paradoxical cellular ca2+ signaling in severe but compensated canine left ventricular hypertrophy","volume":"97","author":"Song","year":"2005","journal-title":"Circ Res"},{"key":"2024043016350280000_cvae045-B111","doi-asserted-by":"crossref","first-page":"H797","DOI":"10.1152\/ajpheart.00374.2022","article-title":"Sex-specific responses to slow progressive pressure overload in a large animal model of HFpEF","volume":"323","author":"Eaton","year":"2022","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024043016350280000_cvae045-B112","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/01.CIR.79.4.872","article-title":"Stress-shortening relations and myocardial blood flow in compensated and failing canine hearts with pressure-overload hypertrophy","volume":"79","author":"Gaasch","year":"1989","journal-title":"Circulation"},{"key":"2024043016350280000_cvae045-B113","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/08941939709032169","article-title":"An adult canine model of progressive left ventricular pressure overload","volume":"10","author":"Keech","year":"1997","journal-title":"J Invest Surg"},{"issue":"5 pt. 2","key":"2024043016350280000_cvae045-B114","first-page":"H949","article-title":"Myocardial blood flow in left ventricular hypertrophy developing in young and adult dogs","volume":"251","author":"Bache","year":"1986","journal-title":"Am J Physiol"},{"key":"2024043016350280000_cvae045-B115","first-page":"212","article-title":"Advancing swine models for human health and diseases","volume":"110","author":"Walters","year":"2013","journal-title":"Mo Med"},{"key":"2024043016350280000_cvae045-B116","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/978-1-4939-8597-5_26","article-title":"Methods in molecular biology","volume":"1816","author":"Bikou","year":"2018","journal-title":"Methods Mol Biol"},{"key":"2024043016350280000_cvae045-B117","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1161\/CIRCHEARTFAILURE.108.814459","article-title":"Large animal models of heart failure: a critical link in the translation of basic science to clinical practice","volume":"2","author":"Dixon","year":"2009","journal-title":"Circ Heart Fail"},{"key":"2024043016350280000_cvae045-B118","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/laban.1215","article-title":"Swine models, genomic tools and services to enhance our understanding of human health and diseases","volume":"46","author":"Walters","year":"2017","journal-title":"Lab Anim (NY)"},{"key":"2024043016350280000_cvae045-B119","doi-asserted-by":"publisher","DOI":"10.3791\/63526","article-title":"A surgical model of heart failure with preserved ejection fraction in Tibetan minipigs","volume":"180","author":"Li","year":"2022","journal-title":"J Vis Exp"},{"key":"2024043016350280000_cvae045-B120","doi-asserted-by":"crossref","first-page":"497841","DOI":"10.1155\/2011\/497841","article-title":"Animal models of cardiovascular diseases","volume":"2011","author":"Zaragoza","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"2024043016350280000_cvae045-B121","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1161\/01.RES.68.5.1458","article-title":"Myocardial angiogenesis and coronary perfusion in left ventricular pressure-overload hypertrophy in the young lamb. Evidence for inhibition with chronic protamine administration","volume":"68","author":"Flanagan","year":"1991","journal-title":"Circ Res"},{"key":"2024043016350280000_cvae045-B122","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00441-020-03206-9","article-title":"The pig as a model for immunology research","volume":"380","author":"Pabst","year":"2020","journal-title":"Cell Tissue Res"},{"key":"2024043016350280000_cvae045-B123","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7150\/ijbs.3.179","article-title":"Advances in swine biomedical model genomics","volume":"3","author":"Lunney","year":"2007","journal-title":"Int J Biol Sci"},{"key":"2024043016350280000_cvae045-B124","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1172\/JCI111351","article-title":"Effects of pressure overload, left ventricular hypertrophy on beta-adrenergic receptors, and responsiveness to catecholamines","volume":"73","author":"Vatner","year":"1984","journal-title":"J Clin Invest"},{"key":"2024043016350280000_cvae045-B125","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1172\/JCI113335","article-title":"Decreased stimulatory guanosine triphosphate binding protein in dogs with pressure-overload left ventricular failure","volume":"81","author":"Longabaugh","year":"1988","journal-title":"J Clin Invest"},{"key":"2024043016350280000_cvae045-B126","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/089419300750059370","article-title":"Experimental aortic stenosis and corresponding left ventricular hypertrophy in sheep","volume":"13","author":"Walther","year":"2000","journal-title":"J Invest Surg"},{"issue":"4 pt. 2","key":"2024043016350280000_cvae045-B127","first-page":"H1036","article-title":"Myocardial function in immature and mature sheep with pressure-overload hypertrophy","volume":"262","author":"Aoyagi","year":"1992","journal-title":"Am J Physiol"},{"key":"2024043016350280000_cvae045-B128","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S1010-7940(03)00514-1","article-title":"A pressure overload model to track the molecular biology of heart failure","volume":"24","author":"Moorjani","year":"2003","journal-title":"Eur J Cardiothorac Surg"},{"key":"2024043016350280000_cvae045-B129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2006.04.037","article-title":"Upregulation of Bcl-2 proteins during the transition to pressure overload-induced heart failure","volume":"116","author":"Moorjani","year":"2007","journal-title":"Int J Cardiol"},{"key":"2024043016350280000_cvae045-B130","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.jacc.2006.05.065","article-title":"Activation of apoptotic caspase cascade during the transition to pressure overload-induced heart failure","volume":"48","author":"Moorjani","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2024043016350280000_cvae045-B131","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijcard.2015.03.156","article-title":"Progression of matrixin and cardiokine expression patterns in an ovine model of heart failure and recovery","volume":"186","author":"Quttainah","year":"2015","journal-title":"Int J Cardiol"},{"key":"2024043016350280000_cvae045-B132","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/age.12049","article-title":"Genetics of serum and muscle lipids in pigs","volume":"44","author":"Casellas","year":"2013","journal-title":"Anim Genet"},{"key":"2024043016350280000_cvae045-B133","doi-asserted-by":"crossref","first-page":"H976","DOI":"10.1152\/ajpheart.2000.279.3.H976","article-title":"Early sequence of cardiac adaptations and growth factor formation in pressure- and volume-overload hypertrophy","volume":"279","author":"Modesti","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024043016350280000_cvae045-B134","doi-asserted-by":"crossref","first-page":"111348","DOI":"10.1016\/j.jbiomech.2022.111348","article-title":"Morphological, functional, and biomechanical progression of LV remodelling in a porcine model of HFpEF","volume":"144","author":"Zheng","year":"2022","journal-title":"J Biomech"},{"issue":"5 pt. 2","key":"2024043016350280000_cvae045-B135","first-page":"H1031","article-title":"Cardiac vasculature and flow during pressure-overload hypertrophy","volume":"251","author":"Breisch","year":"1986","journal-title":"Am J Physiol"},{"key":"2024043016350280000_cvae045-B136","doi-asserted-by":"crossref","first-page":"H1393","DOI":"10.1152\/ajpheart.00871.2005","article-title":"Bioenergetic and functional consequences of stem cell-based VEGF delivery in pressure-overloaded swine hearts","volume":"290","author":"Wang","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024043016350280000_cvae045-B137","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12967-017-1299-0","article-title":"Porcine model of progressive cardiac hypertrophy and fibrosis with secondary postcapillary pulmonary hypertension","volume":"15","author":"Gy\u00f6ngy\u00f6si","year":"2017","journal-title":"J Transl Med"},{"key":"2024043016350280000_cvae045-B138","first-page":"92","article-title":"A porcine model of heart failure with preserved ejection fraction: magnetic resonance imaging and metabolic energetics","volume":"7","author":"Charles","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2024043016350280000_cvae045-B139","doi-asserted-by":"crossref","first-page":"H450","DOI":"10.1152\/ajpheart.00072.2015","article-title":"Myocardial ATP hydrolysis rates in vivo: a porcine model of pressure overload-induced hypertrophy","volume":"309","author":"Xiong","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024043016350280000_cvae045-B140","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00005344-200308000-00018","article-title":"Specific alterations of endothelial signal transduction pathways of porcine epicardial coronary arteries in left ventricular hypertrophy","volume":"42","author":"Malo","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2 pt. 2","key":"2024043016350280000_cvae045-B141","first-page":"H434","article-title":"Collagen characterization in volume-overload- and pressure-overload-induced cardiac hypertrophy in minipigs","volume":"265","author":"Harper","year":"1993","journal-title":"Am J Physiol"},{"key":"2024043016350280000_cvae045-B142","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1093\/cvr\/cvab370","article-title":"Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC working group on myocardial function and the ESC working group on cellular biology of the heart","volume":"118","author":"van der Velden","year":"2022","journal-title":"Cardiovasc Res"},{"key":"2024043016350280000_cvae045-B143","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41467-020-14349-2","article-title":"Preclinical development of a miR-132 inhibitor for heart failure treatment","volume":"11","author":"Foinquinos","year":"2020","journal-title":"Nat Commun"},{"key":"2024043016350280000_cvae045-B144","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/eurheartj\/ehaa898","article-title":"Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human phase 1b randomized, double-blind, placebo-controlled study","volume":"42","author":"T\u00e4ubel","year":"2021","journal-title":"Eur Heart J"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvae045\/56817320\/cvae045.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/120\/5\/461\/57362169\/cvae045.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/120\/5\/461\/57362169\/cvae045.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T17:15:01Z","timestamp":1714497301000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/120\/5\/461\/7617524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":144,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,3,1]]},"published-print":{"date-parts":[[2024,4,30]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvae045","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2024,3,1]]}}}